Literature DB >> 21862666

Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls.

Anne Kristine Amstrup1, Lars Rejnmark, Leif Mosekilde.   

Abstract

OBJECTIVE: Primary hyperparathyroidism (PHPT) is associated with feelings of fatigue and depression, as well as limitation to physical and mental functioning. These quality of life (QoL) characteristics improve after parathyroidectomy. However, whether former patients fully regain QoL compared with healthy controls is largely unknown. DESIGN AND PATIENTS: Cross-sectional study. Fifty-one former PHPT patients, successfully treated by surgery (mean time since parathyroidectomy 7.4 (range 5-15) years), and 51 sex- and age-matched healthy controls.
METHODS: The 36-item Short-Form Health Survey version 2 and the WHO-Five Well-being Index. The surveys included questions on overall physical and mental health, functioning, and limitation in daily life activities.
RESULTS: Former patients scored significantly lower compared with controls in physical functioning (P=0.01), role limitation caused by emotional problems (P=0.01), vitality (P<0.001), and general health (P=0.01). Compared with the controls, cases had a lower median (interquartile range) score of physical component summary (PCS; 54.9 (47.9-58.7) vs 49.6 (45.2-55.9), P=0.03) and mental component summary (MCS; 55.4 (49.7-58.1) vs 52.5 (44.7-55.5), P=0.04). There was no association between time since operation and PCS or MCS. Compared with controls, cases had higher body mass index (BMI; 26.0±4.7 vs 28.8±6.0 kg/m(2), P<0.001) and a higher frequency of cardiovascular diseases (CVD; 41.2 vs 62.7%, P=0.03). After adjustment for differences in BMI and CVD, PCS did no longer differ between groups. However, adjustments did not change the finding of a lower MCS in cases compared with controls.
CONCLUSION: Even though QoL may improve substantially after surgery, former PHPT patients still have reduced QoL compared with healthy controls.

Entities:  

Mesh:

Year:  2011        PMID: 21862666     DOI: 10.1530/EJE-11-0301

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  10 in total

1.  The Associations of Serum Osteocalcin and Cortisol Levels With the Psychological Performance in Primary Hyperparathyroidism Patients.

Authors:  Shu-Min Wang; Yang He; Min-Ting Zhu; Bei Tao; Hong-Yan Zhao; Li-Hao Sun; Jian-Min Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-12       Impact factor: 5.555

Review 2.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

Review 3.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

Review 4.  Asymptomatic primary hyperparathyroidism.

Authors:  Shonni J Silverberg; Marcella D Walker; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

5.  Muscle function is impaired in patients with "asymptomatic" primary hyperparathyroidism.

Authors:  Lars Rolighed; Anne Kristine Amstrup; Niels Frederik Breum Jakobsen; Tanja Sikjaer; Leif Mosekilde; Peer Christiansen; Lars Rejnmark
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

6.  Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Shonni J Silverberg; Bart L Clarke; Munro Peacock; Francisco Bandeira; Stephanie Boutroy; Natalie E Cusano; David Dempster; E Michael Lewiecki; Jian-Min Liu; Salvatore Minisola; Lars Rejnmark; Barbara C Silva; Marcella D Walker; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

7.  Functional magnetic resonance imaging in primary hyperparathyroidism.

Authors:  Yunglin Gazes; Minghao Liu; Melissa Sum; Elaine Cong; Jennifer Kuo; James A Lee; Shonni Silverberg; Yaakov Stern; Marcella Walker
Journal:  Eur J Endocrinol       Date:  2020-07       Impact factor: 6.664

8.  Quality of Life After Surgery or Surveillance for Asymptomatic Primary Hyperparathyroidism: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Shih-Ping Cheng; Jie-Jen Lee; Tsang-Pai Liu; Po-Sheng Yang; Sung-Chen Liu; Yi-Chiung Hsu; Chien-Liang Liu
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

9.  Cognition and cerebrovascular function in primary hyperparathyroidism before and after parathyroidectomy.

Authors:  M Liu; M Sum; E Cong; I Colon; M Bucovsky; J Williams; A Kepley; J Kuo; J A Lee; R M Lazar; R Marshall; S Silverberg; M D Walker
Journal:  J Endocrinol Invest       Date:  2019-10-16       Impact factor: 4.256

Review 10.  Primary Hyperparathyroidism.

Authors:  Leonardo Bandeira; John Bilezikian
Journal:  F1000Res       Date:  2016-01-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.